Cell-cell interaction and tissue factor expression

Blood Coagulation and Fibrinolysis

Volumn 9, Issue SUPPL. 1, 1998, Pages

  Lorenzet, R ^a   Napoleone, E ^a   Celi, A ^b   Pellegrini, G ^a   Di Santo, A ^a  

^a Department of Vascular Medicine and Pharmacology   (Italy)

^b CNR   (Italy)

Author keywords

Endothelium; Monocytes; Platelets; Tissue factor

Indexed keywords

CALNEXIN; FIBRIN; FIBRINOGEN; THROMBOPLASTIN;

ANGIOGENESIS; CELL ACTIVATION; CELL ADHESION; CELL INTERACTION; CONFERENCE PAPER; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; METASTASIS; PATHOGENESIS; PRIORITY JOURNAL; THROMBOCYTE; THROMBOGENESIS; TISSUE INJURY; TUMOR GROWTH;

BLOOD PLATELETS; CELL COMMUNICATION; ENDOTHELIUM, VASCULAR; HUMANS; MONOCYTES; THROMBOPLASTIN;

EID: 0031728319     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (116)

1. Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 1990; 87:6934-6938.
2. Nemerson Y. Tissue factor and hemostasis. Blood 1988; 71:1-8.
3. Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost 1991; 66:67-79.
4. Furie B, Furie BC. Molecular and cellular biology of blood coagulation. N Engl J Med 1992; 326:800-806.
5. Bugge TH, Xiao Q, Kombrinck KW, Flick MJ, Holmback K, Danton MJS, et al. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc Natl Acad Sci USA 1996; 93:6258-6263.
6. Carmeliet P, Mackman N, Moons L, Luther T, Gressens P, Van Vlaenderen I, et al. Role of tissue factor in embryonic blood vessel development. Nature 1996; 383:73-75.
7. Toomey JR, Kratzer KE, Lasky NM, Stanton JJ, Broze GJ Jr. Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 1996; 88:1583-1587.
8. Shoji M, Abe K, Nawroth PP, Rickles FR. Molecular mechanisms linking thrombosis and angiogenesis in cancer. Trends Cardiovasc Med 1997; 7:52-59.
9. Lawson JH, Butenas S, Mann KG. The evaluation of complex-dependent alterations in human factor VIIa. J Biol Chem 1992; 267:4834-4843.
10. Østerud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977; 74:5260-5264.
11. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134:1087-1097.
12. Colucci M, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB, Semeraro N. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983; 71:1893-1896.
13. Lyberg T, Galdal KS, Evensen SA, Prydz H. Cellular cooperation in endothelial cell thromboplastin synthesis. Br J Haematol 1983; 53:85-89.
14. Brox JH, Østerud B, Bjørklid E, Fenton JW II. Production and availability of thromboplastin in endothelial cells: the effects of thrombin, endotoxin and platelets. Br J Haematol 1984; 57:239-246.
15. Faucette KJ, Parker CJ, McCluskey T, Bernshaw NJ, Rodgers GM. Induction of tissue factor activity in endothelial cells and monocytes by a modified form of albumin present in normal human plasma. Blood 1992; 79:2888-2895.
16. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, et al. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990; 172:535-545.
17. Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA Jr. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA 1986; 83:4533-4537.
18. Niemetz J. Coagulant activity of leukocytes. Tissue factor activity. J Clin Invest 1972; 51:307-313.
19. Edwards RL, Rickles FR, Bobrove AM. Mononuclear cell tissue factor: cell of origin and requirements for activation. Blood 1979; 54:359-370.
20. Muhlfelder TW, Niemetz J, Kreutzer D, Beebe D, Ward P, Rosenfeld SI. C5 chemotactic fragment induces leukocyte production of tissue factor activity. J Clin Invest 1979; 63:147-150.
21. Rothberger H, Zimmerman TS, Spiegelberg HL, Vaughan JH. Leukocyte procoagulant activity. Enhancement of production in vitro by IgG and antigen-antibody complexes. J Clin Invest 1977; 59:549-557.
22. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993; 82:513-520.
23. Kornberg A, Catane R, Peller S, Kaufman S, Fridkin M. Tuftsin induces tissue factor-like activity in human mononuclear cells and in monocytic cell lines. Blood 1990; 76:814-819.
24. Ernofsson M, Siegbahn A. Platelet-derived growth factor-BB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor. Thromb Res 1996; 83:307-320.
25. Lorenzet R, Peri G, Locati D, Allavena P, Colucci M, Semeraro N, et al. Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues. Blood 1983; 62:271-273.
26. Lerner RG, Goldstein R, Cummings G. Endotoxin induced disseminated intravascular clotting: evidence that it is mediated by neutrophil production of tissue factor. Thromb Res 1977; 11:253-261.
27. Higure A, Okamoto K, Hirata K, Todoroki H, Nagafuchi Y, Takeda S, et al. Macrophages and neutrophils infiltrating into the liver are responsible for tissue factor expression in a rabbit model of acute obstuctive cholangitis. Thromb Haemost 1996; 75:791-795.
28. Gregory SA, Edgington TS. Tissue factor induction in human monocytes: two distinct mechanisms displayed by different alloantigen responsive T cell clones. J Clin Invest 1985; 76: 2440-2445.
29. Levy GA, Schwartz BS, Edgington TS. The kinetics and metabolic requirements for direct lymphocyte induction of human procoagulant monokines by bacterial lipopolysaccharide. J Immunol 1981; 127:357-363.
30. Gregory SA, Kornbluth RS, Helin H, Remold HG, Edgington TS. Monocyte procoagulant inducing factor: a lymphokine involved in the T cell-instructed monocyte procoagulant response to antigen. J Immunol 1986; 137:3231-3239.
31. Geczy CL. Induction of macrophage procoagulant by products of activated lymphocytes. Haemostasis 1984; 14:400-411.
32. Semeraro N, Biondi A, Lorenzet R, Locati D, Mantovani A, Donati MB. Direct induction of tissue factor synthesis by endotoxin in human macrophages from diverse anatomical sites. Immunology 1983; 50:529-535.
33. Edwards RL, Rickles FR. The role of human T cells (and T cell products) for monocyte tissue factor generation. J Immunol 1980; 125:606-609.
34. Lyberg T, Prydz H. Is lymphocyte co-operation necessary for thromboplastin synthesis by human monocytes? Clin Exp Immunol 1983; 53:731-738.
35. Oeth P, Parry GCN, Mackman N. Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NF-κB/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression. Arterioscler Thromb Vasc Biol 1997; 17:365-374.
36. Bloem LJ, Chen L, Konigsberg WH, Bach R. Serum stimulation of quiescent human fibroblasts induces the synthesis of tissue factor mRNA followed by the appearance of tissue factor antigen and procoagulant activity. J Cell Physiol 1989; 139:418-423.
37. 2+ mobilization and protein kinase C activation. J Clin Invest 1993; 91:547-552.
38. Cui MZ, Parry GC, Edgington TS, Mackman N. Regulation of tissue factor gene expression in epithelial cells. Induction by serum and phorbol 12-myristate 13-acetate. Arterioscler Thromb 1994; 14:807-814.
39. Mackman N. Regulation of the tissue factor gene. FASEB J 1995; 9:883-889.
40. Moll T, Czyz M, Holzmuller H, Hofer-Warbinek R, Wagner E, Winkler H, et al. Regulation of the tissue factor promoter in endothelial cells. Binding of NF-kappa-B, AP-1, and Sp1-like transcription factors. J Biol Chem 1995; 270:3849-3857.
41. de Prost D, Ollivier V, Ternisien C, Chollet-Martin S. Increased monocytc procoagulant activity independent of the lupus anticoagulant in patients with systemic lupus erythematosus. Thromb Haemost 1990; 64:216-221.
42. Idell S, James KK, Levin EG, Schwartz BS, Manchanda N, Maunder RJ, et al. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 1989; 84:695-705.
43. Edwards RL, Levine JB, Green R, Duffy M, Mathews E, Brande W, Rickles FR. Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity. Gastroenterology 1987; 92:329-337.
44. Østerud B, Flaegstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavorable prognosis. Thromb Haemost 1983; 49: 5-7.
45. Violi F, Ferro D, Basili S, Saliola M, Quintarelli C, Alessandri C, Cordova C. Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. Gastroenterology 1995; 109:531-539.
46. Warr TA, Rao LVM, Rapaport SI. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor. Effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood 1990; 75:1481-1489.
47. Taylor FB Jr, Chang A, Ruf W, Morrissey JH, Hinshaw L, Catlett R, et al. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 1991; 33:127-134.
48. Levi M, ten Cate H, Bauer KA, van der Poll T, Edgington TS, Büller HR, et al. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal antibody in chimpanzees. J Clin Invest 1994; 93:114-120.
49. Rickles FR, Edwards RL. Leukocytes and tumor cells in thrombosis. In: Hemostasis and thrombosis. Basic principles and clinical practice. Colman RW, Hirsh J, Marder VJ, Salzman EW (editors). Philadelphia: J.B. Lippincott; 1994. pp. 1164-1179.
50. Costantini V, Zackarski LR. Fibrin and cancer. Thromb Haemost 1993; 69:406-414.
51. Semeraro N, Montemurro P, Conese M, Giordano D, Stella M, Restaino A, et al. Procoagulant activity of mononuclear phagocytes from different anatomical sites in patients with gynecological malignancies. Int J Cancer 1990; 45:251-254.
52. Morgan D, Edwards RL, Rickles FR. Monocyte procoagulant activity as a peripheral marker of clotting activation in cancer patients. Haemostasis 1988; 18:55-65.
53. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86:2839-2843.
54. Tipping PG, Malliaros J, Holdsworth SR. Procoagulant activity expression by macrophages from atheromatous plaques. Atherosclerosis 1989; 79:237-243.
55. Annex BH, Denning SM, Channon KM, Sketch MH Jr, Stack RS, Morrisey JH, Peters KG. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995; 91:619-622.
56. Marmur JD, Thiruvikraman SV, Fyfe BS, Guha A, Sharma SK, Ambrose JA, et al. Identification of active tissue factor in human coronary atheroma. Circulation 1996; 94:1226-1232.
57. Ardissino D, Merlini PA, Ariens R, Coppola R, Bramucci E, Mannucci PM. Tissue-factor antigen and activity in human coronary atherosclerotic plaques. Lancet 1997; 349:769-771.
58. Neri Serneri GG, Abbate R, Gori AM, Attanasio M, Martini F, Giusti B, et al. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation 1992; 86: 790-797.
59. Leatham EW, Bath PMW, Tooze JA, Camm AJ. Increased monocyte tissue factor expression in coronary disease. Br Heart J 1995; 73:10-13.
60. Pfeffer MA, Braunwald E, Moyè LA, Basta L, Brown EJ, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992; 327:669-677.
61. Yusuf S, Pepine CJ, Garces C, Pouleur H, Salem D, Kostis J, et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 1992; 340:1173-1178.
62. Semeraro N, Triggiani R, Montemurro P, Cavallo LG, Colucci M. Enhanced endothelial tissue factor but normal thrombomodulin in endotoxin-treated rabbits. Thromb Res 1993; 71:479-486.
63. Nawroth PP, Handley DA, Esmon CT, Stern DM. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci USA 1986; 83:3460-3464.
64. Østerud B, Tindall A, Brox JH, Olsen JO. Thromboplastin content in the vessel wall of different arteries and organs of rabbits. Thromb Res 1986; 42:323-329.
65. Drake TA, Cheng J, Chang A, Taylor FB Jr. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol 1993; 142:1458-1470.
66. Thiruvikraman SV, Guha A, Roboz J, Taubman MB, Nemerson Y, Fallon JT. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab Invest 1996; 75:451-461.
67. Contrino J, Hair G, Kreutzer DL, Rickles FR. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast cancer. Nature Med 1996; 2:209-215.
68. Faggiotto A, Ross R, Harker L. Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis 1984; 4:323-340.
69. Gerrity RG. The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 1981; 103:181-190.
70. Masuda J, Ross R. Atherogenesis during low level hypercholesterolemia in the nonhuman primate. I. Fatty streak formation. Arteriosclerosis 1990; 10:164-177.
71. Curtiss LK, Black AS, Takagi Y, Plow EF. New mechanism for foam cell generation in atherosclerotic lesions. J Clin Invest 1987; 80:367-373.
72. Bigby TD, Meslier N. Transcellular lipoxygenase metabolism between monocytes and platelets. J Immunol 1989; 143: 1948-1954.
73. Altieri DC, Mannucci PM. Thromboxane generation by human monocytes enhances platelet function. J Exp Med 1986; 164:1815-1820.
74. Schwartz BS, Monroe MC, Human platelet aggregation is initiated by peripheral blood mononuclear cells exposed to bacterial lipopolysaccharidein vitro. J Clin Invest 1986; 78:1136-1141.
75. Semeraro N, Locati D, Colucci M. Leucocyte-dependent platelet activation: an alternative pathway for initiation of blood clotting in inflammation. Agents Actions 1981; 11:553-555.
76. Niemetz J, Marcus AJ. The stimulatory effect of platelets and platelet membranes on the procoagulant activity of leukocytes. J Clin Invest 1974; 54:1437-1443.
77. Pinder PB, Hunt JA, Zacharski LR. In vitro stimulation of monocyte tissue factor activity by autologous platelets. Am J Hematol 1985; 19:317-325.
78. Lorenzet R, Niemetz J, Marcus AJ, Broekman MJ. Enhancement of mononuclear procoagulant activity by platelet 12-hydroxyeicosatetraenoic acid. J Clin Invest 1986; 78:418-423.
79. Østerud B, Bjørklid E. The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. Scand J Haematol 1982; 29:175-184.
80. Amirkhosravi A, Alexander M, May K, Francis DA, Warnes G, Biggerstaff J, Francis JL. The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay. Thromb Haemost 1996; 75:87-95.
81. Hamberg M, Samuelsson B. Prostaglandin endoperoxides: novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci USA 1974; 721:3400-3404.
82. Engstad CS, Lia K, Rekdal Ø, Olsen JO, Østerud B. A novel biological effect of platelet factor 4 (PF4): enhancement of LPS-induced tissue factor activity in monocytes. J Leukoc Biol 1995; 58:575-581.
83. Halvorsen H, Olsen JO, Østerud B. Granulocytes enhance LPS-induced tissue factor activity in monocytes via an interaction with platelets. J Leukoc Biol 1993; 54:275-282.
84. Lorenzet R. Platelet-leukocyte interaction in blood coagulation. In: Trends in Hemostasis. Losonczy H, Dàvid M (editors). Hungary: Academic Press; 1995. pp. 57-66.
85. Berman CL, Yeo E, Wencel-Drake JD, Furie BC, Ginsberg ML, Furie B. A platelet alpha-granule protein that is associated with the plasma membrane after activation: characterization and subcellular localization of platelet activation-dependent granule-external membrane protein. J Clin Invest 1986; 78:130-137.
86. Bonfanti R, Furie BC, Furie B, Wagner DD. PADGEM (GMP-140) is a component of the Weibel-Palade bodies of human endothelial cells. Blood 1989; 73:1109-1112.
87. Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DE A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985; 101:880-886.
88. Sako D, Chang X-J, Barone KM, Vachino G, White HM, Shaw G, et al. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 1993; 75:1179-1186.
89. Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu Y-M, et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992; 359:848-851.
90. Celi A, Pellegrini G, Lorenzet R, De Blasi A, Ready N, Furie BC, Furie B. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci USA 1994; 91:8767-8771.
91. Navarro C, Furie BC, Furie B. Binding of the lectin-EGF domains of P-selectin to PSGL-1 on monocytes is required for upregulation of tissue factor and is independent of CD14 [abstract]. Blood 1996; 88:653A.
92. Weyrich AS, Elstad MR, McEver RP, McIntyre TM, Moore KL, Morrisey JH, et al. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 1996; 97:1525-1534.
93. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-808.
94. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84:2068-2101.
95. Springer T. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76:301-314.
96. Cotran RS. New roles for the endothelium in inflammation and immunity. Am J Pathol 1987; 129:407-413.
97. Hakkert BC, Rentenaar JM, van Mourik JA. Monocytes enhance the bidirectional release of type I plasminogen activator inhibitor by endothelial cells. Blood 1990; 76:2272-2278.
98. Hakkert BC, Rentenaar JM, van Mourik JA. Monocytes enhance endothelial von Willebrand factor release and prostacyclin production with different kinetics and dependency on intercellular contact between these two cell types. Br J Haematol 1992; 80:495-503.
99. Grandone E, Taticchi A, Di Santo A, Malandra R, Margaglione M, Di Minno G, Lorenzet R. Mononuclear leukocytes upregulate mitogen release from endothelial cells. Thromb Haemost 1995; 73:1085A.
100. Marczin N, Antonov A, Papapetropoulos A, Munn DH, Virmani R, Kolodgie FD, et al. Monocyte-induced downregulation of nitric oxide synthase in cultured aortic endothelial cells. Arterioscler Thromb Vasc Biol 1996; 16:1095-1103.
101. Lukacs NW, Strieter RM, Einer VM, Evanoff HL, Burdick M, Kunkel SL. Intercellular adhesion molecule-1 mediates the expression of monocyte-derived MIP-1a during monocyte-endothelial cell interactions. Blood 1994; 83:1174-1178.
102. Takahashi M, Masuyama J-I, Ikeda U, Kasahara T, Kitagawa S-I, Takahashi Y-I, et al. Induction of monocyte chemoattractant protein-1 synthesis in human monocytes during transendothelial migration in vitro. Circ Res 1995; 76:750-757.
103. Takahashi M, Kitagawa S, Masuyama J-I, Ikeda U, Kasahara T, Takahashi Y-I, et al. Human monocyte-endothelial cell interaction induces synthesis of granulocyte-macrophage colony-stimulating factor. Circulation 1996; 93:1185-1193.
104. Napoleone E, Di Santo A, Lorenzet R. Monocytes upregulate endothelial cell expression of tissue factor: a role for cell-cell contact and cross-talk. Blood 1997; 89:541-549.
105. Wharram BL, Fitting K, Kunkel SL, Remick DG, Merritt SE, Wiggins RC. Tissue factor expression in endothelial cell/monocyte cocultures stimulated by lipopolysaccharide and/or aggregated IgG. Mechanisms of cell:cell communication. J Immunol 1991; 146:1437-1445.
106. Collins PW, Noble KE, Reittie JR, Hoffbrand AV, Pasi KJ, Yong KL. Induction of tissue factor expression in human monocyte/ endothelium cocultures. Br J Haematol 1995; 91:963-970.
107. Lo SK, Cheung A, Zheng Q, Silverstein RL. Induction of tissue factor on monocytes by adhesion to endothelial cells. J Immunol 1995; 154:4768-4777.
108. Lewis JC, Jones NL, Hermanns MI, Rohrig O, Klein CL, Kirkpatrick CJ. Tissue factor expression during coculture of endothelial cells and monocytes. Exp Mol Pathol 1995; 62:207-218.
109. Arnaout MA, Lanier LL, Faller DV. Relative contribution of the leukocyte molecules Mo1, LFA-1, and p150,95 (LeuM5) in adhesion of granulocytes and monocytes to vascular endothelium is tissue- and stimulus-specific. J Cell Physiol 1988; 137:305-309.
110. Kuijpers TW, Hakkert BC, van Mourik JA, Roos D. Distinct adhesive properties of granulocytes and monocytes to endothelial cells under static and stirred conditions. J Immunol 1990; 145:2588-2594.
111. Beekhuizen H, Corsèl-van Tilburg AJ, van Furth R. Characterization of monocyte adherence to human macrovascular and microvascular endothelial cells. J Immunol 1990; 145:510-518.
112. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 1993; 11:767-804.
113. Webb DSA, Shimizu Y, Van Seventer GA, Shaw S, Gerrard TL. LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release. Science 1990; 249:1295-1297.
114. Chen W, Knapp W, Majdic O, Stockinger H, Böhmig GA, Zlabinger GJ. Co-ligation of CD31 and FcgRII induces cytokine production in human monocytes. J Immunol 1994; 152:3991-3997.
115. Yurochko AD, Liu DY, Eierman D, Haskill S. Integrins as a primary signal transduction molecule regulating monocyte immediate-early gene induction. Proc Natl Acad Sci USA 1992; 89:9034-9038.
116. Fan S-T, Edgington TS. Integrin regulation of leukocyte inflammatory functions. CD11b/CD18 enhancement of the tumor necrosis factor-α responses of monocytes. J Immunol 1993; 150:2972-2980.